 |
Harlan Bioproducts for Science in vitro monoclonal production program can accelerate your production pipeline while you concentrate on R&D.
From research to full-scale cGMP production (10 mg-200 grams), a flexible cost effective program is available.
Advantages include; lower cost, time savings, easy scale-up, virtually any type of cells, many media options, reduced purification costs, flexibility, and quicker results.
Harlan Bioproducts for Science
www.hbps.com
